Electrical and structural remodeling of the failing ventricle

A A Armoundas1, R Wu, G Juang

  • 1Division of Molecular Cardiobiology, Johns Hopkins University, Ross 844, 720 Rutland Avenue, Baltimore, MD 21205, USA. gtomasel@jhmi.edu

Insights

Heart failure (HF) is a growing public health concern, especially in the elderly. Neurohumoral activation and mechanical stress in HF lead to electrical and structural changes, impairing heart function.

Area of Science:

  • Cardiology
  • Gerontology
  • Public Health

Background:

  • Heart failure (HF) poses a significant public health challenge, particularly in Western societies.
  • The prevalence of HF escalates with age, increasing the societal disease burden as life expectancy rises.
  • HF initially involves adaptive neurohumoral activation to maintain cardiac output.

Purpose of the Study:

  • To elucidate the complex pathophysiological mechanisms underlying heart failure.
  • To understand the progression of cardiac dysfunction in aging populations.
  • To identify the triggers for maladaptive electrical and structural remodeling in the failing heart.

Main Methods:

  • Review of existing literature on heart failure pathophysiology.
  • Analysis of epidemiological data on HF prevalence in the elderly.
  • Examination of the interplay between neurohumoral activation and mechanical stress.

Main Results:

  • Neurohumoral activation and mechanical stress initiate a cascade of detrimental events in the failing heart.
  • These events lead to maladaptive electrical and structural alterations.
  • Both systolic and diastolic heart function are progressively impaired.

Conclusions:

  • Heart failure involves a complex interplay of neurohumoral and mechanical factors.
  • Age-related increases in HF prevalence highlight the need for effective management strategies.
  • Understanding these mechanisms is crucial for developing targeted therapies to improve cardiac function.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Chambers of the Heart01:16

Chambers of the Heart

The human heart is a complex organ made up of four chambers: the right and left atria and the right and left ventricles. These internal chambers are separated by partitions known as the interatrial and interventricular septa. The exterior of the heart features a groove known as the coronary sulcus that demarcates the atria from the ventricles, while the anterior and posterior interventricular sulci distinguish between the two ventricles.
Deoxygenated blood from the body is received in the right...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...